recombinant fowlpox-CEA(6D)/TRICOM vaccine
Sponsors
National Cancer Institute (NCI), H. Kim Lyerly
Conditions
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the PancreasAdenocarcinoma of the RectumAdult Primary Hepatocellular CarcinomaAdult Solid NeoplasmAdvanced Adult Primary Liver CancerBreast Cancer
Phase 1
Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer
TerminatedNCT00048893
Start: 2002-11-30End: 2011-06-30Updated: 2012-04-13
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
CompletedNCT00028496
Start: 2001-11-30Updated: 2013-01-25
Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
TerminatedNCT00009958
Start: 2000-11-30Updated: 2013-05-16
Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer
TerminatedNCT00088933
Start: 2004-06-30Updated: 2014-03-31
Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
CompletedNCT00128622
Start: 2005-09-30End: 2009-05-31Updated: 2012-11-12
Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
CompletedNCT00217373
Start: 2005-06-30End: 2015-03-31Updated: 2015-04-20